Briacell Therap (BCTX) Short Interest Ratio & Short Volume $0.82 +0.05 (+6.49%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.82 0.00 (-0.13%) As of 05:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Briacell Therap Short Interest DataBriacell Therap (BCTX) has a short interest of 329,900 shares, representing 5.20% of the float (the number of shares available for trading by the public). This marks a 56.87% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 735,031 shares to cover all short positions.Current Short Interest329,900 sharesPrevious Short Interest210,300 sharesChange Vs. Previous Month+56.87%Dollar Volume Sold Short$969.91 thousandShort Interest Ratio0.2 Days to CoverLast Record DateJune 30, 2025Outstanding Shares6,776,000 sharesFloat Size6,340,000 sharesShort Percent of Float5.20%Today's Trading Volume3,032,255 sharesAverage Trading Volume735,031 sharesToday's Volume Vs. Average413% Short Selling Briacell Therap? Sign up to receive the latest short interest report for Briacell Therap and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCTX Short Interest Over TimeBCTX Days to Cover Over TimeBCTX Percentage of Float Shorted Over Time Briacell Therap Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025329,900 shares $969.91 thousand +56.9%5.2%0.2 $2.94 6/15/2025210,300 shares $656.14 thousand -59.4%3.3%0.1 $3.12 5/31/2025517,500 shares $1.77 million +205.0%9.7%0.4 $3.42 5/15/2025169,700 shares $495.52 thousand -39.3%3.2%0.1 $2.92 4/30/2025279,400 shares $1.25 million +35.0%5.2%0.2 $4.46 4/15/2025206,900 shares $775.88 thousand +7.8%6.0%0.1 $3.75 3/31/2025191,900 shares $700.44 thousand +2.0%5.5%0.6 $3.65 3/15/2025188,100 shares $722.30 thousand +2.2%5.4%0.6 $3.84 2/28/2025184,100 shares $675.65 thousand -9.0%5.4%0.5 $3.67 2/15/2025202,300 shares $880.01 thousand +113.4%5.9%0.5 $4.35 Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Briacell Therap and its competitors with MarketBeat's FREE daily newsletter. 1/31/202594,800 shares $475.90 thousand -94.2%2.8%0.3 $5.02 1/15/20251,620,000 shares $9.72 million -1.8%4.0%1.2 $6.00 12/31/20241,650,000 shares $932.25 thousand -30.7%4.2%1.1 $0.57 12/15/20242,380,000 shares $1.57 million +245.7%6.0%1 $0.66 11/30/2024688,400 shares $676.28 thousand +28.7%2.1%0.1 $0.98 11/15/2024534,800 shares $318.21 thousand -28.2%1.7%0.1 $0.60 10/31/2024745,100 shares $605.92 thousand +2.4%2.3%0.2 $0.81 10/15/2024727,600 shares $654.62 thousand +62.0%2.3%0.2 $0.90 9/30/2024449,200 shares $557.01 thousand -72.8%1.6%0.1 $1.24 9/15/20241,650,000 shares $924.83 thousand +549.1%6.7%0.5 $0.56 8/31/2024254,200 shares $200.21 thousand -39.1%1.7%0.1 $0.79 8/15/2024417,200 shares $236.97 thousand -10.2%2.7%1.1 $0.57 7/31/2024464,400 shares $349.46 thousand -18.4%3.0%1.2 $0.75 7/15/2024569,400 shares $529.54 thousand +1.1%3.7%1.6 $0.93 6/30/2024563,300 shares $642.16 thousand -10.4%3.6%4.7 $1.14 6/15/2024628,300 shares $892.19 thousand -12.6%4.1%5.2 $1.42 5/31/2024718,900 shares $1.21 million +11.3%4.8%5.9 $1.69 5/15/2024645,700 shares $1.08 million -3.3%4.3%5.6 $1.68 4/30/2024667,700 shares $1.45 million -2.5%4.8%8.9 $2.17 4/15/2024685,000 shares $1.59 million +1.1%4.9%8.1 $2.32 3/31/2024677,900 shares $1.94 million -7.6%4.8%7.2 $2.86 3/15/2024733,300 shares $2.16 million -7.9%5.2%6.8 $2.95 2/29/2024795,900 shares $2.75 million -2.8%5.7%7.7 $3.46 2/15/2024818,800 shares $2.64 million -6.1%5.8%8.3 $3.23 1/31/2024871,900 shares $3.59 million +1.0%6.2%9.2 $4.12 1/15/2024863,700 shares $3.79 million +0.6%6.2%7.6 $4.39 12/31/2023858,500 shares $5.02 million +1.6%6.1%8 $5.85 12/15/2023845,200 shares $3.49 million -11.2%6.0%8.8 $4.13 11/30/2023951,900 shares $5.04 million -2.8%6.8%10.5 $5.29 11/15/2023979,100 shares $4.31 million +3.8%7.0%10 $4.40[No Brainer Gold Play]: “Show me a better investment.” (Ad)A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Click here to get Garrett’s Top Four picks now. 10/31/2023943,400 shares $4.01 million -7.5%7.1%9.2 $4.25 10/15/20231,020,000 shares $5.00 million -2.9%7.7%12 $4.90 9/30/20231,050,000 shares $6.56 million -3.7%8.0%12.5 $6.25 9/15/20231,090,000 shares $6.63 million -3.5%8.3%11.8 $6.08 8/31/20231,130,000 shares $8.12 million +3.7%8.6%11.9 $7.19 8/15/20231,090,000 shares $7.54 million +3.8%8.3%11.8 $6.92 7/31/20231,050,000 shares $7.02 million +1.0%8.0%10 $6.69 7/15/20231,040,000 shares $6.71 million -1.0%9.1%9.4 $6.45 6/30/20231,050,000 shares $6.74 million -4.6%9.2%8.4 $6.42 6/15/20231,100,000 shares $6.67 million -12.7%9.7%8.8 $6.06 5/31/20231,260,000 shares $7.47 million -6.0%11.4%9.9 $5.93 5/15/20231,340,000 shares $8.80 million -3.6%12.2%9.6 $6.57 4/30/20231,390,000 shares $10.34 million -4.1%12.6%9.1 $7.44 4/15/20231,450,000 shares $10.44 million +1.4%13.2%8.6 $7.20 3/31/20231,430,000 shares $10.65 million -4.7%13.9%7.6 $7.45 3/15/20231,500,000 shares $10.50 million -6.3%14.6%7.1 $7.00 2/28/20231,600,000 shares $11.33 million +4.6%15.5%7.2 $7.08 2/15/20231,530,000 shares $12.22 million +1.3%14.9%6.7 $7.99 1/31/20231,510,000 shares $11.29 million +15.3%14.7%6.7 $7.48 1/15/20231,310,000 shares $8.71 million -0.8%12.6%5.1 $6.65 12/30/20221,320,000 shares $5.77 million -5.7%12.7%5.6 $4.37 12/15/20221,400,000 shares $7.87 million No Change13.5%5.6 $5.62 11/30/20221,400,000 shares $7.52 million No Change13.5%4.1 $5.37 11/15/20221,400,000 shares $7.69 million +12.9%13.5%3.8 $5.49 10/31/20221,240,000 shares $6.82 million -10.1%11.9%3.2 $5.50 10/15/20221,380,000 shares $9.12 million +3.8%13.3%3.4 $6.61 9/30/20221,330,000 shares $7.47 million -16.9%12.8%3.4 $5.62 9/15/20221,600,000 shares $12.91 million +2.6%15.4%3.9 $8.07 8/31/20221,560,000 shares $12.12 million +4.0%15.0%4.2 $7.77 8/15/20221,500,000 shares $10.34 million -4.5%14.4%4.3 $6.89 7/31/20221,570,000 shares $10.21 million -10.8%15.7%4.2 $6.50 7/15/20221,760,000 shares $10.70 million +8.0%15.1%4.6 $6.08 6/30/20221,630,000 shares $9.41 million -0.6%14.0%2 $5.77 6/15/20221,640,000 shares $10.61 million -3.0%14.1%1.9 $6.47 5/31/20221,690,000 shares $8.47 million -0.6%14.8%2.1 $5.01 5/15/20221,700,000 shares $8.40 million -9.1%14.9%2 $4.94 4/30/20221,870,000 shares $13.02 million -24.3%15.7%2.2 $6.96 4/15/20222,470,000 shares $21.27 million +27.3%19.4%2.6 $8.61 3/31/20221,940,000 shares $19.67 million No Change15.1%3.2 $10.14 3/15/20221,940,000 shares $15.62 million +6.0%15.1%3.3 $8.05 2/28/20221,830,000 shares $13.96 million No Change13.7%2.1 $7.63 2/15/20221,830,000 shares $14.02 million +10.2%13.7%1.5 $7.66 1/31/20221,660,000 shares $10.49 million -5.7%13.2%1.2 $6.32 1/15/20221,760,000 shares $14.87 million +17.3%14.0%1.2 $8.45 12/31/20211,500,000 shares $12.42 million -13.3%12.0%1 $8.28 12/15/20211,730,000 shares $13.82 million -8.0%13.9%0.9 $7.99 11/30/20211,880,000 shares $18.50 million +8.1%15.8%0.9 $9.84 11/15/20211,740,000 shares $16.58 million +5.5%14.4%0.9 $9.53 10/29/20211,650,000 shares $13.12 million -15.0%13.7%0.8 $7.95 10/15/20211,940,000 shares $15.89 million -16.7%16.2%0.9 $8.19[No Brainer Gold Play]: “Show me a better investment.” (Ad)A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Click here to get Garrett’s Top Four picks now. 9/30/20212,330,000 shares $18.87 million +22.6%19.5%1 $8.10 9/15/20211,900,000 shares $13.62 million +10.5%15.9%0.9 $7.17 8/31/20211,720,000 shares $11.68 million +4.9%14.6%0.7 $6.79 8/13/20211,640,000 shares $9.84 million No Change14.0%0.4 $6.00 BCTX Short Interest - Frequently Asked Questions What is Briacell Therap's current short interest? Short interest is the volume of Briacell Therap shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 329,900 shares of BCTX short. 5.20% of Briacell Therap's shares are currently sold short. Learn More on Briacell Therap's current short interest. What is a good short interest percentage for Briacell Therap? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.20% of Briacell Therap's floating shares are currently sold short. Is Briacell Therap's short interest increasing or decreasing? Briacell Therap saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 329,900 shares, an increase of 56.9% from the previous total of 210,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Briacell Therap's float size? Briacell Therap currently has issued a total of 6,776,000 shares. Some of Briacell Therap's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Briacell Therap currently has a public float of 6,340,000 shares. How does Briacell Therap's short interest compare to its competitors? 5.20% of Briacell Therap's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Briacell Therap: Pliant Therapeutics, Inc. (4.83%), Zura Bio Limited (11.90%), ESSA Pharma Inc. (1.99%), Quince Therapeutics, Inc. (1.29%), Surrozen, Inc. (1.51%), InterCure Ltd. (0.06%), Immix Biopharma, Inc. (1.00%), Acumen Pharmaceuticals, Inc. (3.87%), Immunic, Inc. (9.79%), Genenta Science S.p.A. Unsponsored ADR (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Briacell Therap stock? Short selling BCTX is an investing strategy that aims to generate trading profit from Briacell Therap as its price is falling. BCTX shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Briacell Therap? A short squeeze for Briacell Therap occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTX, which in turn drives the price of the stock up even further. How often is Briacell Therap's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTX, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Pliant Therapeutics Short Interest Zura Bio Short Interest ESSA Pharma Short Interest Quince Therapeutics Short Interest Surrozen Short Interest InterCure Short Interest Immix Biopharma Short Interest Acumen Pharmaceuticals Short Interest Immunic Short Interest Genenta Science Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCTX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Briacell Therap Please log in to your account or sign up in order to add this asset to your watchlist. Share Briacell Therap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
